Suppr超能文献

外周动脉疾病的医学管理

Medical Management of Peripheral Artery Disease.

作者信息

Sullivan Alexander E, Beckman Joshua A

机构信息

Division of Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee.

出版信息

Semin Intervent Radiol. 2023 Jun 16;40(2):119-128. doi: 10.1055/s-0043-57257. eCollection 2023 Apr.

Abstract

Peripheral artery disease (PAD) is a common type of atherosclerotic disease of the lower extremities associated with reduced quality of life and ambulatory capacity. Major adverse cardiovascular events and limb amputations are the leading cause of morbidity and mortality in this population. Optimal medical therapy is therefore critical in these patients to prevent adverse events. Risk factor modifications, including blood pressure control and smoking cessation, in addition to antithrombotic agents, peripheral vasodilators, and supervised exercise therapy are key pillars of medical therapy. Revascularization procedures represent key touch points between patients and health care providers and serve as opportunities to optimize medical therapy and improve long-term patency rates and outcomes. This review summarizes the aspects of medical therapy that all providers should be familiar with when caring for patients with PAD in the peri-revascularization period.

摘要

外周动脉疾病(PAD)是一种常见的下肢动脉粥样硬化疾病,与生活质量下降和行走能力降低相关。主要不良心血管事件和肢体截肢是该人群发病和死亡的主要原因。因此,最佳药物治疗对于预防这些患者的不良事件至关重要。除抗血栓药物、外周血管扩张剂和监督下的运动疗法外,包括血压控制和戒烟在内的危险因素调整是药物治疗的关键支柱。血管重建手术是患者与医疗服务提供者之间的关键接触点,也是优化药物治疗、提高长期通畅率和改善治疗效果的机会。本综述总结了在血管重建围手术期护理PAD患者时所有医疗服务提供者都应熟悉的药物治疗方面。

相似文献

1
Medical Management of Peripheral Artery Disease.外周动脉疾病的医学管理
Semin Intervent Radiol. 2023 Jun 16;40(2):119-128. doi: 10.1055/s-0043-57257. eCollection 2023 Apr.
3
Contemporary Medical Management of Peripheral Artery Disease.当代外周动脉疾病的医学管理
Circ Res. 2021 Jun 11;128(12):1868-1884. doi: 10.1161/CIRCRESAHA.121.318258. Epub 2021 Jun 10.
4
7
Management of Peripheral Arterial Disease: Lifestyle Modifications and Medical Therapies.外周动脉疾病的管理:生活方式改变与药物治疗
J Soc Cardiovasc Angiogr Interv. 2022 Oct 28;1(6):100513. doi: 10.1016/j.jscai.2022.100513. eCollection 2022 Nov-Dec.
9
Do we have a unified consensus on antithrombotic management of PAD?我们是否对 PAD 的抗栓治疗有统一的共识?
Int Angiol. 2021 Jun;40(3):229-239. doi: 10.23736/S0392-9590.21.04597-1. Epub 2021 Mar 19.

本文引用的文献

1
Understanding Study Drug Discontinuation Through EUCLID.通过EUCLID了解研究药物停用情况。
Front Cardiovasc Med. 2022 Jul 15;9:947645. doi: 10.3389/fcvm.2022.947645. eCollection 2022.
4
Summoning STRENGTH to Question the Placebo in REDUCE-IT.在REDUCE-IT试验中鼓起勇气质疑安慰剂效应
Circulation. 2021 Aug 10;144(6):407-409. doi: 10.1161/CIRCULATIONAHA.121.054539. Epub 2021 Aug 9.
5
Cilostazol for intermittent claudication.西洛他唑治疗间歇性跛行。
Cochrane Database Syst Rev. 2021 Jun 30;6(6):CD003748. doi: 10.1002/14651858.CD003748.pub5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验